Preventive role of carvedilol in adriamycin-induced cardiomyopathy

Abstract

Prophylactic use of carvedilol in patients receiving anthracycline protected systolic functions of the left ventricle. Carvedilol can be a potential drug which can ameliorate ADR-induced CMP.